These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17228474)

  • 21. [HIV eradication--facts and fiction].
    Jaeger H; Wolf E
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV and sexual dysfunction.
    Colebunders R; Florence E; Schrooten W; Enzlin P
    Int J STD AIDS; 2003 Jan; 14(1):69. PubMed ID: 12590805
    [No Abstract]   [Full Text] [Related]  

  • 23. Uncertain generalizability of switch studies.
    Rhame FS
    Clin Infect Dis; 2003 Apr; 36(8):1089. PubMed ID: 12684930
    [No Abstract]   [Full Text] [Related]  

  • 24. Running with scissors: using antiretroviral therapy without monitoring viral load.
    Smith DM; Schooley RT
    Clin Infect Dis; 2008 May; 46(10):1598-600. PubMed ID: 18419496
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of pregnancy on HIV disease progression during the era of highly active antiretroviral therapy.
    Chen PL; Weaver M; Kwok C; Morrison CS
    J Infect Dis; 2008 Apr; 197(7):1075-6; author reply 1076-7. PubMed ID: 18419544
    [No Abstract]   [Full Text] [Related]  

  • 26. Regression of HIV-associated mucosa-associated lymphoid tissue lymphoma during highly active anti-retroviral therapy.
    Ishimaru F
    Clin Infect Dis; 2008 Apr; 46(7):1124. PubMed ID: 18444837
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 28. Summaries for patients. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and patient outcomes.
    Ann Intern Med; 2007 Apr; 146(8):I28. PubMed ID: 17438312
    [No Abstract]   [Full Text] [Related]  

  • 29. High frequency of antiretroviral drug resistance among HIV-infected adults receiving first-line highly active antiretroviral therapy in N'Djamena, Chad.
    Koyalta D; Charpentier C; Beassamda J; Rey E; Si-Mohamed A; Djemadji-Oudjeil N; Bélec L
    Clin Infect Dis; 2009 Jul; 49(1):155-9. PubMed ID: 19480574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV and antiretroviral therapy in the brain: neuronal injury and repair.
    Ellis R; Langford D; Masliah E
    Nat Rev Neurosci; 2007 Jan; 8(1):33-44. PubMed ID: 17180161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance mutation patterns in plasma and breast milk of HIV-infected women receiving highly-active antiretroviral therapy for mother-to-child transmission prevention.
    Andreotti M; Guidotti G; Galluzzo CM; Mancinelli S; Germano P; Pirillo MF; Marazzi MC; Vella S; Palombi L; Giuliano M
    AIDS; 2007 Nov; 21(17):2360-2. PubMed ID: 18090293
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 33. Two versus three-class antiretroviral therapy in antiretroviral-naive patients in different time periods of the HAART era.
    Taffé P; Bucher HC; Flepp M; Battegay M
    AIDS; 2007 Feb; 21(4):537-8. PubMed ID: 17301581
    [No Abstract]   [Full Text] [Related]  

  • 34. Myelodysplastic syndrome with complex karyotype associated with long-term highly active antiretroviral therapy.
    Rieg S; Lübbert M; Kern WV; Timme S; Gärtner F; Rump JA
    Br J Haematol; 2009 Jun; 145(5):670-3. PubMed ID: 19344389
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions.
    Djuricich P; Vázquez E
    Posit Aware; 2009; 20(2):56-8. PubMed ID: 19280746
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug interactions chart. An abbreviated, at-a-glance guide to HIV drug interactions.
    Diaz-Linares M; Vázquez E
    Posit Aware; 2008; 19(1):50-2. PubMed ID: 18546578
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectiveness and durability of non-nucleoside reverse transcriptase inhibitor-based therapy in HIV clinical practice.
    Kan VL
    AIDS; 2007 Apr; 21(7):880-2. PubMed ID: 17415048
    [No Abstract]   [Full Text] [Related]  

  • 40. [Major breakthroughs in the medical treatment].
    Kirk O; Gerstoft J; Lundgren JD; Obel N
    Ugeskr Laeger; 2009 Mar; 171(10):787-9. PubMed ID: 19265601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.